JUDY CARRICO: Open Payments
NPI 1649251349 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$637 in 36 payments from 21 companies in 2025. Trend: 2023 $490 · 2024 $510 · 2025 $637
Food & beverage: $637
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $80 |
| AstraZeneca Pharmaceuticals LP | 5 | $79 |
| Amgen Inc. | 3 | $60 |
| Lilly USA, LLC | 3 | $51 |
| Novo Nordisk Inc | 3 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Exact Sciences Corporation | 2 | $28 |
| Abbott Laboratories | 1 | $22 |
| Astellas Pharma US Inc | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
Products named: UBRELVY, OTEZLA, Kerendia, Ozempic, MOUNJARO, Cologuard Collection Kit, QULIPTA, FREESTYLE LIBRE 3.
Industry payments across KY — which companies pay providers there.
